drugset / Trial / NCT00334152
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
RandomizedParallel-groupDouble-blindPrevention
Summary
This study is being conducted to see if adding GW679769 (casopitant) to ZOFRAN will significantly decrease the number of patients who experience nausea and vomiting after surgery.
Timeline
- Start
- 2006-03
- Primary completion
- 2006-07
- Completion
- 2006-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Casopitant | Small molecule | 30 mg | Intravenous |
Indications
No indication recorded.